Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
Piscitelli Dominic sold 600 Oric Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Piscitelli Dominic (Chief Financial Officer) sold 600 Oric Pharmaceuticals, Inc. shares at an average US$13.51 for US$8,105 under a trading plan, leaving 69,828 shares. Filed Sep 25, 2026 (Form 4).
- Sold
- 600 shares
- Price
- US$13.51 average (US$13.50 to US$13.51)
- Value
- US$8,105
- Holding after
- 69,828 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Option exercise | 600 | US$4.36 | 70,428 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 100 | US$13.50 | 70,328 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 500 | US$13.51 | 69,828 | Direct |
Source
Related
- Oric Pharmaceuticals, Inc.
- Piscitelli Dominic
- Oric Pharmaceuticals, Inc. shareholders
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Heyman Richard A. · Jul 28, 2026
- Form 4 · Heyman Richard A. · Jul 8, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026